PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Neuroscience, Middlebury College, the University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.\', \'Department of Psychiatry, the University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.\', \'Department of Pediatric Infectious Diseases, and the University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.\', \'Department of Pediatric Hematology Oncology, the University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1089/adt.2021.014
?:hasPublicationType
?:journal
  • Assay and drug development technologies
is ?:pmid of
?:pmid
?:pmid
  • 34375133
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.033
?:rankingScore_hIndex
  • 50
?:title
  • Repurposing Psychotropic Agents for Viral Disorders: Beyond Covid.
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34375133>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34375133>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all